The table below shows CUMBERLAND PHARMACEUTICALS INC's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Revenue
$9.13M
$13.68M
$8.29M
$10.84M
$11.71M
$10.44M
Cost of revenue
$1.93M
-
$988.76K
$2.01M
$1.43M
-
Gross profit
-
-
-
-
-
-
R&D
$1.46M
-
$1.25M
$1.47M
$1.30M
-
CPIX annual revenue (10-K history)
CUMBERLAND PHARMACEUTICALS INC reported annual revenue of $44.52M for fiscal year 2025. That is up 17.6% from $37.87M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $33.03M (FY 2016) to $44.52M. Figures come from the company's audited annual reports as filed with the SEC.